BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 18262553)

  • 1. Leptin augments proliferation of breast cancer cells via transactivation of HER2.
    Soma D; Kitayama J; Yamashita H; Miyato H; Ishikawa M; Nagawa H
    J Surg Res; 2008 Sep; 149(1):9-14. PubMed ID: 18262553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasoactive intestinal peptide (VIP) induces transactivation of EGFR and HER2 in human breast cancer cells.
    Valdehita A; Bajo AM; Schally AV; Varga JL; Carmena MJ; Prieto JC
    Mol Cell Endocrinol; 2009 Apr; 302(1):41-8. PubMed ID: 19101605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of epidermal growth factor receptor transactivation in the activation of cytosolic phospholipase A(2) in leptin protection of salivary gland acinar cells against ethanol cytotoxicity.
    Slomiany BL; Slomiany A
    J Physiol Pharmacol; 2009 Jun; 60(2):49-55. PubMed ID: 19617645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transactivation of HER2 by vasoactive intestinal peptide in experimental prostate cancer: Antagonistic action of an analog of growth-hormone-releasing hormone.
    Sotomayor S; Carmena MJ; Schally AV; Varga JL; Sánchez-Chapado M; Prieto JC; Bajo AM
    Int J Oncol; 2007 Nov; 31(5):1223-30. PubMed ID: 17912451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptin-regulated gene expression in MCF-7 breast cancer cells: mechanistic insights into leptin-regulated mammary tumor growth and progression.
    Perera CN; Chin HG; Duru N; Camarillo IG
    J Endocrinol; 2008 Nov; 199(2):221-33. PubMed ID: 18715880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptin signaling in breast cancer: an overview.
    Cirillo D; Rachiglio AM; la Montagna R; Giordano A; Normanno N
    J Cell Biochem; 2008 Nov; 105(4):956-64. PubMed ID: 18821585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epinephrine stimulates esophageal squamous-cell carcinoma cell proliferation via beta-adrenoceptor-dependent transactivation of extracellular signal-regulated kinase/cyclooxygenase-2 pathway.
    Liu X; Wu WK; Yu L; Sung JJ; Srivastava G; Zhang ST; Cho CH
    J Cell Biochem; 2008 Sep; 105(1):53-60. PubMed ID: 18452159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of epidermal growth factor receptor inhibitor alone and in combination with cisplatin on growth of vulvar cancer cells.
    Kim SH; Song YC; Kim SH; Jo H; Song YS
    Ann N Y Acad Sci; 2009 Aug; 1171():642-8. PubMed ID: 19723115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of reactive oxygen species in urotensin II-induced proliferation of cardiac fibroblasts.
    Chen YL; Liu JC; Loh SH; Chen CH; Hong CY; Chen JJ; Cheng TH
    Eur J Pharmacol; 2008 Sep; 593(1-3):24-9. PubMed ID: 18671962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of 4-aryl-5-cyano-2H-1,2,3-triazoles as inhibitor of HER2 tyrosine kinase.
    Cheng ZY; Li WJ; He F; Zhou JM; Zhu XF
    Bioorg Med Chem; 2007 Feb; 15(3):1533-8. PubMed ID: 17174554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation.
    Catalano S; Giordano C; Rizza P; Gu G; Barone I; Bonofiglio D; Giordano F; Malivindi R; Gaccione D; Lanzino M; De Amicis F; Andò S
    J Cell Physiol; 2009 Mar; 218(3):490-500. PubMed ID: 18988190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extra-virgin olive oil polyphenols inhibit HER2 (erbB-2)-induced malignant transformation in human breast epithelial cells: relationship between the chemical structures of extra-virgin olive oil secoiridoids and lignans and their inhibitory activities on the tyrosine kinase activity of HER2.
    Menendez JA; Vazquez-Martin A; Oliveras-Ferraros C; Garcia-Villalba R; Carrasco-Pancorbo A; Fernandez-Gutierrez A; Segura-Carretero A
    Int J Oncol; 2009 Jan; 34(1):43-51. PubMed ID: 19082476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TOB1 is regulated by EGF-dependent HER2 and EGFR signaling, is highly phosphorylated, and indicates poor prognosis in node-negative breast cancer.
    Helms MW; Kemming D; Contag CH; Pospisil H; Bartkowiak K; Wang A; Chang SY; Buerger H; Brandt BH
    Cancer Res; 2009 Jun; 69(12):5049-56. PubMed ID: 19491269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-dependent leptin expression in breast cancer cells.
    Bartella V; Cascio S; Fiorio E; Auriemma A; Russo A; Surmacz E
    Cancer Res; 2008 Jun; 68(12):4919-27. PubMed ID: 18559540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-targeting insulin-like growth factor I receptor and HER2: dramatic effects of HER2 inhibitors on nonoverexpressing breast cancer.
    Chakraborty AK; Liang K; DiGiovanna MP
    Cancer Res; 2008 Mar; 68(5):1538-45. PubMed ID: 18316619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitogenic and anti-apoptotic actions of adipocyte-derived hormone leptin in prostate cancer cells.
    Hoda MR; Popken G
    BJU Int; 2008 Aug; 102(3):383-8. PubMed ID: 18341625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mathematical model for the effects of HER2 overexpression on cell proliferation in breast cancer.
    Eladdadi A; Isaacson D
    Bull Math Biol; 2008 Aug; 70(6):1707-29. PubMed ID: 18648887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cleavage of the HER2 ectodomain is a pervanadate-activable process that is inhibited by the tissue inhibitor of metalloproteases-1 in breast cancer cells.
    Codony-Servat J; Albanell J; Lopez-Talavera JC; Arribas J; Baselga J
    Cancer Res; 1999 Mar; 59(6):1196-201. PubMed ID: 10096547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin activates STAT and ERK2 pathways and induces gastric cancer cell proliferation.
    Pai R; Lin C; Tran T; Tarnawski A
    Biochem Biophys Res Commun; 2005 Jun; 331(4):984-92. PubMed ID: 15882975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrphostin AG1478 suppresses proliferation and invasion of human breast cancer cells.
    Zhang YG; Du Q; Fang WG; Jin ML; Tian XX
    Int J Oncol; 2008 Sep; 33(3):595-602. PubMed ID: 18695891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.